Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities

Abstract

Progressive memory loss and cognitive impairment are the main clinical manifestations of Alzheimer’s disease (AD). Currently, there is no effective drug available for the treatment of AD. Previous studies have demonstrated that the cognitive impairment of AD is associated with oxidative stress and the inhibition of AKT and ERK phosphorylation. Grape seed proanthocyanidin extract (GSPE) has been shown to have strong antioxidant effect and can protect the nervous system from oxidative stress damage. This study aimed to investigate the protective effect of GSPE on the cognitive and synaptic impairments of AD using a sporadic AD rat model induced by intracerebroventricular (ICV) injection of streptozotocin (STZ) (ICV-STZ). Rats were treated with GSPE (50, 100, or 200 mg/kg every day) by intragastrical (ig.) administration for continuous 7 weeks, and ICV-STZ (3 mg/kg) was performed on the first day and third day of week 5. Learning and memory abilities were assessed by the Morris water maze (MWM) test at week 8. After behavioral test, hippocampal long-term potentiation (LTP) was recorded, and the levels of malondialdehyde (MDA), superoxide dismutases (SOD), glutathione (GSH) and the protein expression of AKT and ERK were measured in the hippocampus and cerebral cortex of rats. Our study revealed that ICV-STZ significantly impaired the working learning ability and hippocampal LTP of rats, significantly increased the levels of MDA, and decreased the activity of SOD and GSH in the hippocampus and cerebral cortex. In contrast, GSPE treatment prevented the impairment of cognitive function and hippocampal LTP induced by ICV-STZ, decreased the level of MDA, and increased the level of SOD and GSH. Furthermore, Western blot results showed that GSPE treatment could prevent the loss of AKT and ERK activities in the hippocampus and cerebral cortex induced by ICV-STZ. Our findings demonstrate that GSPE treatment could ameliorate the impairment of cognitive ability and hippocampal synaptic plasticity in a rat model of sporadic AD by inhibiting oxidative stress and preserving AKT and ERK activities. Therefore, GSPE may be an effective agent for the treatment of cognitive deficits associated with sporadic AD.

Keywords

grape seed proanthocyanidin extract / Alzheimer’s disease / cognitive ability / synaptic plasticity / oxidative stress / AKT/ERK signaling

References

[1] ShiptonOA, LeitzJR, DworzakJ, et al.. Tau protein is required for amyloid β-induced impairment of hippocampal long-term potentiation. J Neurosci, 2011, 31(5): 1688-1692

[2] KandimallaR, ThirumalaV, ReddyPH. Is Alzheimer’s disease a Type 3 Diabetes? A critical appraisal. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(5): 1078-1089

[3] SwomleyAM, ButterfieldDA. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics. Arch Toxicol, 2015, 89(10): 1669-1680

[4] QiY, DouDQ, JiangH, et al.. Arctigenin attenuates learning and memory deficits through PI3k/Akt/GSK-3β pathway reducing tau hyperphosphorylation in Aβ-induced AD mice. Planta Med, 2017, 83(1–02): 51-56

[5] ZhangB, WangY, LiH, et al.. Neuroprotective effects of salidroside through PI3K/Akt pathway activation in Alzheimer’s disease models. Drug Des Devel Ther, 2016, 10: 1335-1343

[6] FaucherP, MonsN, MicheauJ, et al.. Hippocampal injections of oligomeric amyloid β-peptide (1–42) induce selective working memory deficits and long-lasting alterations of ERK signaling pathway. Front Aging Neurosci, 2015, 7: 245

[7] BaoJ, LiuW, ZhouHY, et al.. Epigallocatechin-3-gallate alleviates cognitive deficits in APP/PS1 mice. Curr Med Sci, 2020, 40(1): 18-27

[8] LiuS, ChengW, ShaoJ, et al.. Notoginseng saponin Rg1 prevents cognitive impairment through modulating APP processing in Aβ 1-42-injected rats. Curr Med Sci, 2019, 39(2): 196-203

[9] ShahmohamadyP, EidiA, MortazaviP, et al.. Effect of sinapic acid on memory deficits and neuronal degeneration induced by intracerebroventricular administration of streptozotocin in rats. Pol J Pathol, 2018, 69(3): 266-277

[10] BagchiD, GargA, KrohnRL, et al.. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol, 1997, 95(2): 179-189

[11] PengN, ClarkJT, PrasainJ, et al.. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol, 2005, 289(3): R771-R775

[12] CuiXP, LiBY, GaoHQ, et al.. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J Nutr Sci Vitaminol (Tokyo), 2008, 54(4): 321-328

[13] PrasainJK, PengN, DaiY, et al.. Liquid chromatography tandem mass spectrometry identification of proantho-cyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine, 2009, 16(2–3): 233-243

[14] FerruzziMG, LoboJK, JanleEM, et al.. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease. J Alzheimers Dis, 2009, 18(1): 113-124

[15] WangD, HoL, FaithJ, et al.. Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease beta-amyloid oligomerization. Mol Nutr Food Res, 2015, 59(6): 1025-1040

[16] GutierresJM, CarvalhoFB, SchetingerMR, et al.. Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer’s type. Life Sci, 2014, 96(1–2): 7-17

[17] NaghizadehB, MansouriMT, GhorbanzadehB, et al.. Protective effects of oral crocin against intracerebroventricular streptozotocin-induced spatial memory deficit and oxidative stress in rats. Phytomedicine, 2013, 20(6): 537-542

[18] ShohamS, BejarC, KovalevE, et al.. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology, 2007, 52(3): 836-843

[19] Salkovic-PetrisicM, Osmanovic-BarilarJ, BrucknerMK, et al.. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study. J Neural Transm (Vienna), 2011, 118(5): 765-772

[20] DuelliR, SchrockH, KuschinskyW, et al.. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci, 1994, 12(8): 737-743

[21] LannertH, HoyerS. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci, 1998, 112(5): 1199-1208

[22] Salkovic-PetrisicM, KnezovicA, HoyerS, et al.. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J Neural Transm (Vienna), 2013, 120(1): 233-252

[23] HeoJH, LeeSR, LeeST, et al.. Spatial distribution of glucose hypometabolism induced by intracerebro-ventricular streptozotocin in monkeys. J Alzheimers Dis, 2011, 25(3): 517-523

[24] GriebP. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism. Mol Neurobiol, 2016, 53(3): 1741-1752

[25] ZhouM, ChenS, PengP, et al.. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3beta. Biochem Biophys Res Commun, 2019, 511(1): 154-160

[26] YangY, LiY, WangW, et al.. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Pharmacol Biochem Behav, 2014, 122: 30-36

[27] BhardwajM, DeshmukhR, KaundalM, et al.. Pharmacological induction of hemeoxygenase-1 activity attenuates intracerebroventricular streptozotocin induced neurocognitive deficit and oxidative stress in rats. Eur J Pharmacol, 2016, 772: 43-50

[28] SannaRS, MuthangiS, B K, CS, et al.. Grape seed proanthocyanidin extract and insulin prevents cognitive decline in type 1 diabetic rat by impacting Bcl-2 and Bax in the prefrontal cortex. Metab Brain Dis, 2019, 34(1): 103-117

[29] AbhijitS, SubramanyamM, DeviSA. Grape seed proanthocyanidin and swimming exercise protects against cognitive decline: a study on M1 acetylcholine receptors in aging male rat brain. Neurochem Res, 2017, 42(12): 3573-3586

[30] ChenC, ZhengY, WuT, et al.. Oral administration of grape seed polyphenol extract restores memory deficits in chronic cerebral hypoperfusion rats. Behav Pharmacol, 2017, 28: 207-213

[31] CitriA, MalenkaRC. Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology, 2008, 33(1): 18-41

[32] NevesG, CookeSF, BlissTV. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci, 2008, 9(1): 65-75

[33] SultanaR, ButterfieldDA. Oxidative modification of brain proteins in Alzheimer’s disease: perspective on future studies based on results of redox proteomics studies. J Alzheimers Dis, 2013, 33(Suppl1): S243-S251

[34] TexelSJ, MattsonMP. Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer’s disease. Antioxid Redox Signal, 2011, 14(8): 1519-1534

[35] YangWN, HanH, HuXD, et al.. The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress. Pharmacol Biochem Behav, 2013, 114–115: 31-36

[36] ChenZ, ZhongC. Oxidative stress in Alzheimer’s disease. Neurosci Bull, 2014, 30(2): 271-281

[37] VinaJ, LloretA, GiraldoE, et al.. Antioxidant pathways in Alzheimer’s disease: possibilities of intervention. Curr Pharm Des, 2011, 17(35): 3861-3864

[38] WangX, WangW, LiL, et al.. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta, 2014, 1842(8): 1240-1247

[39] ZindaMJ, JohnsonMA, PaulJD, et al.. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res, 2001, 7(8): 2475-2479

[40] ObenauerJC, CantleyLC, YaffeMB. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res, 2003, 31(13): 3635-3641

[41] GrilloCA, PiroliGG, HendryRM, et al.. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res, 2009, 1296: 35-45

[42] HorwoodJM, DufourF, LarocheS, et al.. Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci, 2006, 23(12): 3375-3384

[43] TiwariSK, SethB, AgarwalS, et al.. Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an amyloid-β toxin-induced Alzheimer rat model via the phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/beta-catenin pathway. J Biol Chem, 2015, 290(47): 28 540-28 558

[44] MaQL, Harris-WhiteME, UbedaOJ, et al.. Evidence of Aβ- and transgene-dependent defects in ERK-CREB signaling in Alzheimer’s models. J Neurochem, 2007, 103(4): 1594-1607

[45] KimEK, ChoiEJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta, 2010, 1802(4): 396-405

[46] ChoHJ, KimSK, JinSM, et al.. IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia, 2007, 55(3): 253-262

[47] WebsterB, HansenL, AdameA, et al.. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol, 2006, 65(2): 142-151

[48] KoYH, ShimKY, KimSK, et al.. Lespedeza bicolor extract improves amyloid β 25–35-induced memory impairments by upregulating BDNF and activating Akt, ERK, and CREB signaling in mice. Planta Med, 2019, 85(17): 1363-1373

[49] SoukhakLariR, Borhani-HaghighiA, FarsadroohA, et al.. The effect of cinnamaldehyde on passive avoidance memory and hippocampal Akt, ERK and GSK-3β in mice. Eur J Pharmacol, 2019, 859: 172530

[50] MuhammadT, AliT, IkramM, et al.. Melatonin rescue oxidative stress-mediated neuroinflammation/neurodegeneration and memory impairment in scopola-mine-induced amnesia mice model. J Neuroimmune Pharmacol, 2019, 14(2): 278-294